| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5882825 | Clinical Lymphoma Myeloma and Leukemia | 2015 | 6 Pages |
Abstract
Pretreatment evaluation rarely leads to a change in management and is not helpful in predicting subsequent cardiomyopathy. Guidelines that recommend evaluation of left ventricular function in all patients before anthracycline-based chemotherapy should be reexamined.
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
John Steuter, Robert Bociek, Fausto Loberiza, Daniel Mathers, James Armitage, Julie Vose, Martin Bast, Shikhar Saxena, Thomas Porter, Philip Bierman,